Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:EFA NYSE:NVS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEFAiShares MSCI EAFE ETF$95.30+0.2%$91.69$72.14▼$95.53$68.73B0.8614.63 million shs12.81 million shsNVSNovartis$132.350.0%$123.57$96.06▼$133.55$279.58B0.641.85 million shs1.38 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEFAiShares MSCI EAFE ETF0.00%+2.64%+3.58%+7.37%+15.18%NVSNovartis0.00%+7.00%+2.04%+8.43%+16.20%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEFAiShares MSCI EAFE ETF$95.30+0.2%$91.69$72.14▼$95.53$68.73B0.8614.63 million shs12.81 million shsNVSNovartis$132.350.0%$123.57$96.06▼$133.55$279.58B0.641.85 million shs1.38 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEFAiShares MSCI EAFE ETF0.00%+2.64%+3.58%+7.37%+15.18%NVSNovartis0.00%+7.00%+2.04%+8.43%+16.20%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEFAiShares MSCI EAFE ETF 0.00N/AN/AN/ANVSNovartis 2.10Hold$120.33-9.08% DownsideCurrent Analyst Ratings BreakdownLatest NVS and EFA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/27/2025NVSNovartisWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy (B)9/12/2025NVSNovartisThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral ➝ Sell$119.00 ➝ $118.008/21/2025NVSNovartisDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy8/8/2025NVSNovartisMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeUnderweight ➝ Equal Weight$123.00(Data available from 10/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEFAiShares MSCI EAFE ETFN/AN/AN/AN/AN/AN/ANVSNovartis$50.32B5.56$10.70 per share12.37$21.59 per share6.13Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEFAiShares MSCI EAFE ETFN/AN/A16.48∞N/AN/AN/AN/AN/ANVSNovartis$11.94B$6.8719.2615.021.8325.64%41.08%16.83%10/28/2025 (Estimated)Latest NVS and EFA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/28/2025Q3 2025NVSNovartis$2.28N/AN/AN/A$13.70 billionN/A7/17/2025Q2 2025NVSNovartis$2.38$2.42+$0.04$2.06$13.94 billion$14.05 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEFAiShares MSCI EAFE ETF$2.572.70%N/AN/AN/ANVSNovartis$2.601.96%N/A37.85%N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEFAiShares MSCI EAFE ETFN/AN/AN/ANVSNovartis0.530.820.62Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEFAiShares MSCI EAFE ETF79.80%NVSNovartis13.12%Insider OwnershipCompanyInsider OwnershipEFAiShares MSCI EAFE ETFN/ANVSNovartis0.01%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEFAiShares MSCI EAFE ETFN/A721.20 millionN/ANot OptionableNVSNovartis75,8832.11 billion2.11 billionOptionableNVS and EFA HeadlinesRecent News About These Companies3 Reasons Growth Investors Will Love Novartis (NVS)5 hours ago | zacks.comWhy Novartis (NVS) is a Top Momentum Stock for the Long-TermOctober 6 at 10:51 AM | zacks.comThese 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your RadarOctober 6 at 9:51 AM | zacks.comBoston Common Asset Management LLC Sells 11,877 Shares of Novartis AG $NVSOctober 5 at 5:11 AM | marketbeat.comNovartis medicines to retain same names and quality under Nevian: MD MusawathOctober 5 at 4:22 AM | tbsnews.netTPublic Employees Retirement System of Ohio Sells 88,654 Shares of Novartis AG $NVSOctober 5 at 3:13 AM | marketbeat.comNovartis AG $NVS Shares Acquired by QRG Capital Management Inc.October 4 at 5:54 AM | marketbeat.com3,511 Shares in Novartis AG $NVS Purchased by Pure Financial Advisors LLCOctober 4 at 4:04 AM | marketbeat.comNovartis: Superstars Entresto And Kisqali Fuel Market OutperformanceOctober 3 at 9:07 AM | seekingalpha.comNovartis AG $NVS Shares Purchased by Abundance Wealth CounselorsOctober 3 at 6:41 AM | marketbeat.comNovartis AG $NVS Shares Sold by Mirae Asset Global Investments Co. Ltd.October 3 at 5:32 AM | marketbeat.comPatriot Financial Group Insurance Agency LLC Raises Stake in Novartis AG $NVSOctober 3 at 5:14 AM | marketbeat.comNovartis AG $NVS Shares Bought by HB Wealth Management LLCOctober 3 at 3:45 AM | marketbeat.comNew Bill: Senator Richard Blumenthal introduces S. 2842: Stop CMV Act of 2025October 2, 2025 | quiverquant.comQNovartis AG (NVS) Hit a 52 Week High, Can the Run Continue?October 2, 2025 | zacks.comNovartis AG $NVS Shares Bought by Truist Financial CorpOctober 2, 2025 | marketbeat.comGreenleaf Trust Has $1.61 Million Stock Holdings in Novartis AG $NVSOctober 2, 2025 | marketbeat.comNovartis AG (NYSE:NVS) Receives $120.33 Average PT from BrokeragesOctober 2, 2025 | americanbankingnews.comNovartis Secures First FDA Approval of Oral BTK Inhibitor for Chronic HivesOctober 1, 2025 | biospace.comBNovartis (NYSE:NVS) Reaches New 52-Week High - Here's WhyOctober 1, 2025 | marketbeat.comNovartis gets FDA approval for oral CSU treatment RhapsidoOctober 1, 2025 | za.investing.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSoundHound Breaks Critical Resistance: How High Can It Get Now?By Thomas Hughes | September 28, 2025The Fed Cut Rates: What Now for the S&P 500 and Equity Markets?By Thomas Hughes | September 18, 2025Why Datavault May Be the Penny AI Stock Investors Have Waited ForBy Nathan Reiff | September 22, 20253 Hot Tech Stocks With Bullish Charts and Ample UpsideBy Thomas Hughes | September 15, 2025Novartis' Moonshot Cancer Therapy Could Be Future Growth DriverBy Chris Markoch | September 9, 2025NVS and EFA Company DescriptionsiShares MSCI EAFE ETF NYSEARCA:EFA$95.30 +0.22 (+0.23%) Closing price 04:10 PM EasternExtended Trading$95.54 +0.23 (+0.25%) As of 05:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.iShares MSCI EAFE ETF, formerly iShares MSCI EAFE Index Fund (the Fund), is an exchange-traded fund. The Fund's investment objective is to seek investment results that correspond to the price and yield performance of its underlying index, MSCI EAFE Index (the Index). The Index has been developed by MSCI Inc. as an equity benchmark for its international stock performance. The Index includes stocks from Europe, Australasia and the Far East. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund's investment advisor is BlackRock Fund Advisors.Novartis NYSE:NVS$132.35 -0.04 (-0.03%) Closing price 03:59 PM EasternExtended Trading$132.28 -0.07 (-0.06%) As of 05:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. The company was incorporated in 1996 and is headquartered in Basel, Switzerland. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Marvell Insiders Buy Shares—Should Investors Follow Suit? Behind D-Wave's Massive Week (And Why Rivals Also Popped) Cheap Chipotle? Why CMG Stock Could Be Ready for a Comeback Alphabet: After Its Best Quarter in Decades, Is It Time to Buy? Best Stocks Under $15? 3 Low-Priced Picks With Upside After Trump Deal, Can Meta Stock Withstand TikTok’s Onslaught? Starbucks Stock Slumps; This Competitor Shows Strength Broadcom’s VMware Push Takes Aim at Microsoft, Google, & Amazon Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
